جست‌وجوی استاد و پژوهشگر

Ambrose Agweyuمشاهده پروفایل

استاد

• Infectious Disease Epidemiology
• Global Health
• Pediatric Health
• +۳ مورد دیگر

Professor Ambrose Agweyu is a faculty member at the London School of Hygiene & Tropical Medicine (LSHTM), specifically within the Department of Infectious Disease Epidemiology and International Health under the Faculty of Epidemiology and Population Health. He specializes in pediatric and infectious disease epidemiology, with a focus on global health challenges in Africa. His research addresses gaps in understanding pneumonia mortality disparities, health policy adaptation, and vaccine efficacy through large-scale studies like the SEARCH trial and the Kenya Multi-Site Serosurveillance (KEMIS) collaboration. Professor Agweyu also explores the intersection of dietary aflatoxin exposure and severe childhood pneumonia, contributing to evidence-based health interventions. His work emphasizes integrating routine health services with research and surveillance, particularly in low-resource settings. Notable projects include adapting WHO guidelines for pneumonia risk stratification in Kenya and evaluating HIV prevention knowledge in postconflict regions of South Sudan. Agweyu collaborates closely with institutions such as the Kenya Medical Research Institute (KEMRI) and has contributed to high-impact publications in BMJ , The Lancet , and BMC Infectious Diseases . His research aims to strengthen health systems through improved data utilization, advocacy, and policy implementation, addressing both immediate pandemic responses and long-term childhood health challenges. While no formal academic awards are explicitly listed, his leadership in pivotal studies and his inaugural lecture at LSHTM underscore his contributions to advancing global health equity. His advisory and grant-related activities remain unspecified in the provided texts, though his collaborations and trials imply significant institutional support. Agweyu’s work is deeply embedded in African health systems, with a particular focus on Kenya, aiming to reduce preventable mortality and improve healthcare outcomes through innovative methodologies and policy-oriented research.

Nidhi Sofatمشاهده پروفایل

استاد

• Rheumatology
• Osteoarthritis
• Inflammation Mechanisms
• +۵ مورد دیگر

Professor Nidhi Sofat is a Professor of Rheumatology at St George's, University of London, and a Consultant Rheumatologist at St George's University Hospitals NHS Foundation Trust. She leads the NIHR Integrated Academic Programme for Clinical Academic Trainees, overseeing research and training programs such as the PGCert in Research Skills and Methods. She qualified in medicine from University College London (1996) with First Class Honours, completed specialist rheumatology training in 2007, and earned her PhD from the Kennedy Institute of Rheumatology (Imperial College London). Her research focuses on understanding pain and inflammation in musculoskeletal diseases, particularly osteoarthritis and rheumatoid arthritis. Her group pioneered the Osteoarthritis Bone Score (OABS), the first histological scoring system for bone marrow lesions in osteoarthritis. Key research areas include mechanisms of pain sensitization, imaging techniques (MRI), clinical trials (e.g., DUPRO, PAPO), and collaborations with institutions like the University of Nottingham and Royal Veterinary College. She has received awards such as the Michael Mason Prize (2013) and Wellcome Trust Fellowship (2003). Her clinical roles include managing general rheumatology, inflammatory arthritis, and osteoarthritis at the Hotung Centre. She has contributed to national guidelines via the Arthritis and Musculoskeletal Alliance (ARMA) and served on committees like the British Society for Rheumatology's Heberden Committee. Major grants include funding from NIHR, Versus Arthritis, and the Wellcome Trust. Collaborations span academic and industry partners, including Pfizer and Merck. Her translational research facility bridges clinical and experimental work, aiming to improve diagnostic tools and therapies for arthritis.

Scott Richard Floydمشاهده پروفایل

دانشیار

• Radiation Oncology
• Brain Tumor Research
• DNA Damage Response
• +۷ مورد دیگر

Scott Richard Floyd is the Gary Hock and Lyn Proctor Associate Professor of Radiation Oncology at Duke University School of Medicine, with secondary appointments as Associate Professor of Radiation Oncology and Assistant Research Professor in Pharmacology and Cancer Biology. He is also a Member of the Duke Cancer Institute and serves as Associate Radiation Director of the Duke Center for Brain and Spine Metastasis and Associate Program Director of the Duke Radiation Oncology Residency Program. Dr. Floyd received his M.D. and Ph.D. from Yale University in 2002. His professional training includes: Internship in Internal Medicine at Hospital of Saint Raphael (2002-2003) Residency in Radiation Oncology at Harvard Medical School, Harvard Radiation Oncology Program (2003-2007) Clinical Investigator position at MIT Koch Institute for Integrative Cancer Research (2012-) Dr. Floyd's research focuses on DNA damage signaling and repair in brain tumor cells, particularly investigating how chromatin changes mediated by epigenetic modifiers affect the DNA damage response (DDR). His lab develops small animal irradiation techniques and mouse models of glioblastoma to test the effects of epigenetic writers and readers on DDR in clinically relevant model systems. He aims to identify strategies to enhance tumor cell killing while protecting normal brain tissues from radiation damage. His work on brain slice models provides a platform for studying stroke, Alzheimer's disease, Huntington's disease, and brain tumors while reducing animal use. Analysis of Dr. Floyd's recent publications reveals a strong focus on brain metastases, radiation necrosis, and the application of artificial intelligence in radiation oncology. His work increasingly integrates radiogenomics, machine learning, and novel radiation techniques to improve outcomes for patients with brain tumors. There's a clear trend toward interdisciplinary collaboration, particularly in combining radiation therapy with immunotherapy and targeted agents, as evidenced by his leadership in the Consortium for Intracranial Metastasis Academic Research (CIMARa). Dr. Floyd has secured significant research funding, including: NEUROD1 function in SCLC fate and plasticity (NIH, 2024-2029) Synthetic lethality with BET bromodomain inhibition (American Cancer Society, 2025-2026) ASPET SURF Institutional Award (2018-2028) Multiple NIH R01 grants supporting his research on DNA damage response and brain tumor biology Dr. Floyd leads the Floyd Lab, which focuses on studying mechanisms of DNA damage signaling and repair in brain tumor and other mammalian cells. His lab utilizes advanced techniques including small animal irradiation, mouse models of glioblastoma, and organotypic brain slice culture platforms. He is also involved in Project Brainslice, which develops experimental model systems using brain slices to research new treatments for brain diseases. His clinical expertise centers on the treatment of benign, primary, and metastatic tumors of the brain and spine, making him a key figure in Duke's brain and spine metastasis program.

Nilay Patelمشاهده پروفایل

دانشیار

• Drug Discovery
• Cell Cycle Regulation
• Signal Transduction
• +۳ مورد دیگر

Dr. Nilay Patel is an Associate Professor in the Department of Biological Science at California State University, Fullerton (CSUF). His research focuses on drug discovery, particularly the anti-proliferative effects of niclosamide and related compounds on cancer cells, with collaborations in chemistry and biochemistry. He investigates signal transduction pathways and gene expression regulation in cell cycle processes. Dr. Patel teaches courses in cellular/molecular biology, stem cell biology, and related advanced topics. Education: PhD, The State University of New York, Stony Brook BS, University of Cincinnati Research Interests: Design and testing of anti-cancer compounds targeting β-catenin reduction Impact of signal transduction pathways on cancer proliferation Collaborative drug development with CSUF Chemistry & Biochemistry Department Publications Trends: His work bridges pharmacology and cell biology, emphasizing stem cell pluripotency, neurodegenerative disease mechanisms, and aging-related biomarkers. Key themes include caloric restriction effects on amyloid accumulation and glial cell functions. Awards/Grants: Bridges to Stem Cell Research (BSCR) Program Advising & Mentorship: Supervised multiple student co-authors in stem cell and cancer biology research projects. Active in training through internships (BIOL 495C) and advanced seminars.

Eduardo Maldonadoمشاهده پروفایل

دانشیار

• Mitochondrial Metabolism
• Cancer Bioenergetics
• Voltage-Dependent Anion Channels (VDAC)
• +۵ مورد دیگر

Eduardo Maldonado is an Associate Professor in the Drug Discovery and Biomedical Sciences department at the College of Pharmacy, Medical University of South Carolina (MUSC) . His research focuses on mitochondrial metabolism in cancer cells, T cells, and cancer stem cells, particularly targeting mechanisms regulating Voltage-Dependent Anion Channels (VDAC) to develop therapeutic strategies. Education: DVM from Universidad Nacional del Centro (1986), PhD in Human Pathophysiology from Universidad Nacional del Sur (2001), Postdoctoral training at MUSC (2006, 2010), Predoctoral research at University of the Basque Country (1999). Research Interests: Mitochondrial metabolism regulation in cancer, VDAC-targeted small molecules, T cell immunometabolism, and cancer stem cell biology. His lab (established in 2015) explores how modulating VDAC channels through tubulin interactions or NADH-binding pockets can alter tumor proliferation and survival. Article Trends: Recent publications highlight VDAC's role in cancer bioenergetics, immunometabolic reprogramming (e.g., H2S-Prdx4 axis), and synergistic drug combinations. Earlier works emphasize mitochondrial ROS, lipid metabolism, and Golgi stress in disease contexts. Labs & Teams: Leads a research group at MUSC's College of Pharmacy, affiliated with the Developmental Cancer Therapeutics Program at Hollings Cancer Center. His work bridges mitochondrial physiology, cancer metabolism, and pharmacological intervention.

Laura Tiptonمشاهده پروفایل

استادیار

• Microbiome Analysis
• Bacterial-Fungal Interactions
• Statistical Ecology
• +۴ مورد دیگر

Laura Tipton is an Assistant Professor in the Department of Mathematics & Statistics at James Madison University (JMU), affiliated with the College of Science and Mathematics. Her research focuses on microbiome dynamics across diverse habitats such as human lungs, aerobiota, invertebrate guts, and fermented foods, emphasizing bacterial-fungal interactions and robust statistical methodologies. She integrates techniques from ecology, machine learning, and graph theory, with side projects in digital humanities, data visualization, and data feminism. Education: PhD in Computational Biology (2016), University of Pittsburgh/Carnegie Mellon University MS in Statistics (2011), George Washington University BA in Biostatistics (2007), University of Virginia Her research interests span microbiome analysis, microbial interactions, and interdisciplinary data science. Recent work includes studies on airborne fungal DNA dynamics, fungal contributions to neonatal lung diseases, and psychobiotic field developments. She emphasizes methodological innovation in microbiome studies and advocates for inclusive data practices. While no formal awards or grants are listed, her work reflects significant contributions to collaborative projects like the Global Spore Sampling Project and Pacific Innovations, Knowledge, and Opportunities (PIKO) Program. Laura’s advising focuses on mentoring students in interdisciplinary projects at the intersection of mathematics, biology, and computational science.

• Genomics
• Epigenetics
• Bioinformatics
• +۳ مورد دیگر

Dr. Gary Hon is an Assistant Professor at UT Southwestern Medical Center affiliated with the Cecil H. and Ida Green Center for Reproductive Biology Sciences and the Lyda Hill Department of Bioinformatics. He leads a research program focused on decoding the complexity of the human genome through two primary directions: understanding the molecular basis of cell state for regenerative medicine applications, and elucidating how non-coding variants contribute to development and disease. His lab employs integrative techniques at the interface of gene regulation, epigenetics, genome engineering, single-cell genomics, and bioinformatics. His research interests span genomics, epigenetics, bioinformatics, gene regulation, stem cell biology, and disease mechanisms. Dr. Hon earned his graduate degree from UC San Diego's Bioinformatics and Systems Biology Program and completed post-doctoral training in Dr. Bing Ren's lab before joining UT Southwestern in 2015. Dr. Hon has received significant recognition including the CPRIT Scholar award and NIH Director’s New Innovator Award. His recent publications demonstrate a focus on advanced genomic techniques including Perturb-Seq optimization, single-cell transcriptomics in cancer and reproductive biology, enhancer network mapping, and stem cell modeling of human development.

Akinyemi I. Ojesinaمشاهده پروفایل

استادیار

• Cancer Genomics
• Tumor Ecology
• HPV-Associated Cancers
• +۶ مورد دیگر

Akinyemi I. Ojesina, MD, PhD is an Assistant Professor in the Department of Obstetrics & Gynecology at the Medical College of Wisconsin (MCW). He leads the Ojesina Oncopathogenomics Laboratory, which investigates the underlying causes of cancer through the lens of tumor ecology, where microbes synergize with genomic alterations to influence tumor initiation, progression, response to therapy, and prognosis. His work bridges translational genomics, metatranscriptomics, molecular epidemiology, and precision oncology. Dr. Ojesina's research program focuses on three primary areas: genomic characterization of molecular drivers in women's cancers, biology of atypical cervical cancers (particularly HPV-independent tumors), and the role of tumor microbiome in cancer initiation and progression. His laboratory applies cutting-edge genomic analyses and laboratory experiments to interrogate population-based patient samples, cell lines, and animal models. A key methodological contribution is his co-development of PathSeq, a computational tool for identifying microbial sequences in high-throughput sequencing data. His recent publications demonstrate a strong emphasis on cervical cancer genomics, with particular attention to HPV-related mechanisms, genomic alterations, and potential therapeutic targets. Across his work, Dr. Ojesina integrates multiple approaches including genomic sequencing, transcriptomic analysis, and functional validation to uncover novel insights into cancer biology, with implications for diagnostic biomarkers and predictive models in both local and global health contexts. Dr. Ojesina leads an active research team comprising postdoctoral researchers and fellows, and has secured significant funding from the National Cancer Institute for his project 'Molecular Markers for Tumors Associated with Extrachromosomal HPV' (2024-2029). His collaborative approach is evident in numerous multi-institutional publications, including major contributions to The Cancer Genome Atlas (TCGA) and other large consortia focused on cervical cancer genomics. His work has appeared in high-impact journals including Nature, Nature Genetics, and Cancer Cell.

Mary Beth Grahamمشاهده پروفایل

استاد

• Infectious Disease
• HIV Infection
• Infections in Immunocompromised Patients
• +۴ مورد دیگر

Mary Beth Graham, MD, FIDSA, FACP is a Professor of Medicine with tenure at the Medical College of Wisconsin, where she serves as Associate Chief for the Division of Infectious Disease. She is also the Medical Director of Infection Prevention and Control at Froedtert Hospital and the Infection Prevention Program Director for the Medical College of Wisconsin. Dr. Graham is a Board Certified Internist and Infectious Disease specialist who joined the faculty at the Medical College of Wisconsin as an Assistant Professor of Medicine/Infectious Diseases in February 2002. Dr. Graham received her MD from Northwestern University Medical School in Chicago (1984), completed her Residency in Internal Medicine at the University of Washington Affiliated Hospitals in Seattle (1984-1987), and completed her Fellowship in Infectious Diseases at Washington University School of Medicine in St. Louis (1988-1991). Dr. Graham's clinical expertise includes HIV infection and associated complications, infections in immunocompromised individuals (including transplant recipients), influenza treatment and prevention, and the prevention of transmission of hospital-associated infections. She has an active outpatient clinical practice and also attends on the inpatient transplant and general infectious disease services. Her research has focused on infection control, particularly related to C. difficile, carbapenem-resistant organisms, and most recently on COVID-19 related complications including thrombosis and immune responses. Her publication record demonstrates a strong focus on clinical infectious disease research, with numerous studies on infections in immunocompromised hosts, antimicrobial resistance, and viral pathogenesis. Her work spans clinical trials, epidemiological studies, case reports, and immunological investigations, showing both clinical relevance and scientific rigor across multiple sub-specialties within infectious diseases. Best Doctors in America Top Doctor (Castle Connolly/Milwaukee Magazine) Best Teaching Physician at Froedtert Hospital by Department of Medicine residents (2013) MCW Outstanding Medical Student Teacher award (2015) Dr. Graham has demonstrated exceptional commitment to medical education, having received multiple teaching awards. As the Infectious Disease Fellowship Program Director, she plays a pivotal role in training the next generation of infectious disease specialists. Her administrative leadership in infection prevention and control reflects her significant contributions to hospital epidemiology and patient safety, with practical applications of her research directly impacting clinical practice and hospital policy. Dr. Graham maintains an active clinical practice with a focus on complex infectious disease cases, particularly in immunocompromised patients. Her dual expertise in clinical care and infection prevention makes her a key resource for managing challenging cases and developing institutional protocols for infection control.

Timothy A. Yapمشاهده پروفایل

استاد

• Cancer Therapeutics
• Immunotherapy
• DNA Damage Response (DDR)
• +۳ مورد دیگر

Dr. Timothy A. Yap is a Medical Oncologist and Physician-Scientist at The University of Texas MD Anderson Cancer Center, holding the Ransom Horne, Jr. Endowed Professorship for Cancer Research. He serves as Vice President and Head of Clinical Development in the Therapeutics Discovery Division and is a Professor in the Department of Investigational Cancer Therapeutics (Phase I Program) and the Department of Thoracic/Head and Neck Medical Oncology. His research focuses on developing molecularly targeted agents and immunotherapies, particularly targeting the DNA damage response (DDR) and novel biomarker-driven approaches. He leads clinical trials for agents like ATR, PARP1, and YAP/TEAD inhibitors, and has expertise in immunotherapy combinations, including PD-1/PD-L1 and other checkpoint inhibitors. Education: BSc (First Class Honors) in Immunology and Infectious Diseases from Imperial College London, MBBS from Imperial College London, PhD in Molecular Pharmacology from The Institute of Cancer Research. He completed clinical training at the Royal Marsden Hospital and Oxford. Research Interests: First-in-human trials, combinatorial drug development, translational biomarker analysis, and precision medicine. His work spans DDR inhibitors, epigenetic targets (EZH2/BET), metabolic pathways (Glutaminase/OXPHOS), and immune-oncology therapies. Grants & Awards: Active grants include NIH/NCI R01, DOD grants, V Foundation Scholar grant, and Golfers against Cancer grant. He has received prestigious awards for clinical research and leadership. Affiliations: Editor of Cancer Discovery , Associate Editor of British Journal of Cancer , and active in global oncology committees (AACR, ASCO, ESMO). He mentors early-career researchers and chairs academic workshops.

André Bueno Gamaمشاهده پروفایل

استادیار

• Plant Pathology
• Disease Epidemiology
• Sugarcane Diseases
• +۲ مورد دیگر

André Bueno Gama is Assistant Professor in the Department of Plant Pathology and Crop Physiology at Louisiana State University's College of Agriculture. He specializes in applied and fundamental research on sugarcane diseases affecting Louisiana's agricultural industry. Education: PhD in Plant Pathology, University of Florida (2021) MSc in Plant Pathology, University of São Paulo (2017) BS in Agronomy, University of São Paulo (2015) Dr. Gama's research focuses on the etiology, epidemiology, and management of economically significant sugarcane diseases including red rot, smut, Sugarcane Yellow Leaf Virus, mosaic virus, and ratoon stunt disease. His program employs interdisciplinary approaches with breeders and entomologists to develop integrated disease management strategies. His recent publications (2008-2023) demonstrate expertise in disease management systems, fungicide efficacy, molecular diagnostics, and decision-support tools for crop protection. Research emphasizes practical applications for sugarcane, citrus, strawberry, and turfgrass production systems. Dr. Gama teaches PLHL 7083 (Epidemiology and Crop Loss Assessment), training graduate students in disease dynamics, prediction models, and management strategies. His extension program monitors disease outbreaks and delivers timely solutions to Louisiana growers.

Aileen Keatingمشاهده پروفایل

استاد

• Reproductive Toxicology
• Environmental Health
• Animal Science
• +۳ مورد دیگر

Dr. Aileen Keating is a Professor in the Department of Animal Science at Iowa State University, Ames, Iowa. Her research focuses on reproductive toxicology, particularly the effects of environmental chemicals (e.g., perfluorooctanoic acid, zearalenone) and stressors (e.g., heat stress, obesity) on ovarian and hepatic physiology in animal models. She investigates molecular mechanisms underlying ovotoxicity, DNA damage responses, and proteomic changes in mice and swine. Education: PhD in Biochemistry (National University of Ireland, Galway, 2003), MSc in Biomedical Sciences (University of Ulster, 1999), BSc in Microbiology (National University of Ireland, 1998). Research emphasizes interdisciplinary approaches to understand how toxicants and metabolic conditions impact reproductive health. Key areas include developmental origins of ovarian disorders, aryl hydrocarbon receptor-mediated toxicity of PCBs, and heat stress effects on porcine reproduction. Collaborations include studies on pelvic organ prolapse in sows and biomarker identification for postpartum dysgalactia syndrome. Her work integrates proteomics, transcriptomics, and genomic analyses, with publications addressing obesity-DNA damage interactions, glyphosate effects on oocytes, and molecular responses to endocrine disruptors. She leads studies on toxicant-induced folliculogenesis alterations and mitigation strategies via dietary or pharmacological interventions. Grants and collaborations focus on translational research bridging animal models and human health implications. Active in mentoring and graduate education, contributing to collaborative programs in reproduction science.

Krystle J. McLaughlinمشاهده پروفایل

دانشیار

• Protein X-ray Crystallography
• Biochemistry
• Biophysics
• +۳ مورد دیگر

Krystle J. McLaughlin is an Associate Professor of Chemistry at Vassar College, where she has been since 2017. She earned a B.A. in Physics from Colgate University (2006) and a PhD in Biophysics from the University of Rochester (2011), followed by a postdoctoral fellowship in pedagogical training and research at the University of North Carolina at Chapel Hill’s SPIRE program. Her research focuses on biochemical and biophysical studies of microbial proteins, particularly antibiotic resistance mechanisms in pathogens like Staphylococcus and Salmonella , using protein x-ray crystallography and cryo-electron microscopy. She is an elected member of the US National Committee for Crystallography. Teaching responsibilities include Biochemistry (Chem 272), Biophysical Chemistry (Chem 326), and Protein Crystallography (Chem 295). McLaughlin’s lab emphasizes undergraduate research, with recent grants including a 2022 Cottrell Scholar Award ($100,000) supporting research and teaching development. She has balanced her career with motherhood, leveraging tenure-clock extensions and childcare arrangements during the pandemic. Her pandemic-era innovations include recorded lectures and iPad-based teaching tools to enhance accessibility. Her research articles span structural biology of bacterial enzymes, conjugative proteins, and gut microbiome enzymes. McLaughlin collaborates on initiatives to improve STEM education equity, including developing course-based research experiences (CUREs) and placement tests for incoming chemistry students.

Carlo Ferri Mariniمشاهده پروفایل

استادیار

• Aerobic Exercise Testing
• Resistance Exercise Prescription
• Exercise Physiology
• +۳ مورد دیگر

Dr. Carlo Ferri Marini is an Assistant Professor at the Department of Human Movement Sciences, University of Groningen and University Medical Center Groningen. He holds a PhD cum laude from the University of Urbino, with additional studies at Colorado Mesa University and University College Dublin. His research focuses on optimizing exercise testing and prescription in healthy and clinical populations, particularly in aerobic and resistance exercise physiology. He collaborates internationally and serves as an Academic Editor for BMC Sports Science, Medicine and Rehabilitation and PeerJ . Key areas of research include exercise intensity methods, lifestyle interventions for breast cancer survivors, and cardiometabolic health. Notable projects include the MOVIS clinical trial on exercise and nutrition programs for cancer survivors and the TRIPL-A trial for type 2 diabetes management. His work emphasizes improving the benefit-to-risk ratio of physical activity through evidence-based approaches. Dr. Marini’s recent publications explore topics such as pedaling cadence effects on metabolic responses, gut microbiota changes in breast cancer survivors, and the validity of exercise intensity metrics. He also investigates the role of exercise in mitigating tumorigenic activity and enhancing quality of life in clinical populations. Collaborations span institutions globally, reflecting his commitment to interdisciplinary research. His research has been featured in journals like Scientific Reports , European Journal of Sport Science , and Frontiers in Oncology . Dr. Marini is affiliated with the SMART Movements research group, advancing knowledge in movement sciences and health. His work bridges clinical and applied research, aiming to translate findings into practical guidelines for improving public health outcomes.

• Tuberculosis Pathogenesis
• Mycobacterium tuberculosis
• Cell Wall Physiology
• +۳ مورد دیگر

Christopher M. Sassetti is a Professor in the Department of Microbiology at the University of Massachusetts Chan Medical School (UMass Chan Medical School) and T.H. Chan School of Medicine. His research focuses on the pathogenesis of Mycobacterium tuberculosis, specifically understanding how the bacterium adapts to host environments, acquires nutrients, regulates its cell wall physiology, and survives antibiotic treatment. He completed his BS in Biology at Santa Clara University and his PhD in Immunology at the University of California, San Francisco. Dr. Sassetti leads the Sassetti Lab, which employs genetic, biochemical, and systems biology approaches to study tuberculosis. His work has identified critical metabolic pathways and survival mechanisms in M. tuberculosis, including cholesterol utilization and cell wall synthesis regulation. He holds additional academic roles in the Morningside Graduate School of Biomedical Sciences, including the Immunology and Microbiology Program, MD/PhD Program, and Postbaccalaureate Research Education Program. Recent research highlights include studies on host immune responses to tuberculosis, antibiotic efficacy under infection conditions, and the role of genetic interactions in pathogen survival. His lab has discovered that host fatty acid metabolism and autophagy pathways play key roles in restricting bacterial growth. Dr. Sassetti has been recognized as a Damon Runyon Foundation Scholar and has contributed to high-impact publications in Immunity , Science , and Cell . Current projects include understanding nutrient acquisition in vivo, phosphosignaling regulation of cell wall synthesis, and metabolic mechanisms driving antibiotic tolerance. Collaborative efforts with institutions like the Morningside Graduate School and global networks drive translational research toward novel tuberculosis therapies and vaccines.